% | $
Quotes you view appear here for quick access.

Peregrine Pharmaceuticals, Inc. Message Board

  • jyardagg jyardagg Sep 23, 2012 1:49 AM Flag

    If bavituximab is working against stage IV pancreatic cancer

    they are 3 months into the Pancreatic trial. tThey could be seeing something that makes them believe bavi is working against a very aggressive form of cancer. It's the ultimate test, the holy grail of achievment and nobody ever "expects" a new drug to actually be effective, so far anyway.

    But "if" they may be seeing something, they should not neccessarily partner anytime too soon. If bavi works against pancreatic, PPHM does not neccessarily even need big Pharma unless they bring something extraordinary to the table..

    PPHM has avid manufacturing. They can mass produce Bavi without Big Pharma.

    If bavi is effective against Pancreatic cancer , PPHM would go to $100 a share within 3 trading days. With that market cap PPHM can do a lot and become a Big Pharma themselves.

    If bavi is showing something against Pancreatic cancer in patients with such little hope at that stage it would be a huge breakthrough. nobody expects that though. Pancreatic cancer is a vary hard cancer . nobody expects it.

    PPHM is moving because of the lung trial data. BUT If Bavi is also showing some positive results against Pancreatic...

    watch that PPHM. they would not even need a big Pharma .. IF...

    But Merck KGaA could be ready to pounce like a big cat. They have reasons.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.31+0.05(+3.97%)Nov 27 1:00 PMEST